Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 in healthy subjects
NCT02429102Phase 1Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Apr 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of elismetrep (2 arms), sponsored by Mitsubishi Tanabe Pharma. Primary endpoints: Vital Signs at 14 days, Electrocardiogram at 14 days and 4 more. Started Apr 2015; status: completed.
02
Drugs
elismetrep
Beyond the preview
Go deeper on NCT02429102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429102.